← All organizations
Ochsner Health System
Academic/HospitalWebsite ↗
Also known as: Director, Pulmonary Hypertension | Jose Soberon, MD | Ochnser Clinic Foundation | Ochsneer Clinic Foudnation | Ochsner | Ochsner Health System | Ochsner Health Systems | Richard Deichmann, MD | Robert Ramirez | Siobhan Trotter
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1999Last known activity
Oct 1, 2024
Timeline
1940s
- Jan 1, 1942
Ochsner Health System— Founded
Drugs by trial phase (63 distinct, 43 trials)
Phase 4 (19 own, 0 via acquisition)
Phase 3 (13 own, 0 via acquisition)
Phase 2 (10 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (20 own, 0 via acquisition)
Indications
Studied for
- Adenoma, Islet Cell
- Apudoma
- Brain Diseases
- Brain Neoplasms
- Carcinoid Tumor
- Carcinoma
- Carcinoma, Neuroendocrine
- Clostridium Infections
- Communicable Diseases
- CREST Syndrome
- Delayed Graft Function
- End Stage Liver Disease
- Familial Primary Pulmonary Hypertension
- Finger Injuries
- Hand Injuries
- Hepatic Encephalopathy
- Hypertension
- Hypertension, Pulmonary
- Infections
- Ischemia
- Joint Diseases
- Kidney Diseases
- Leukemia
- Leukemia, Lymphoid
- Liver Cirrhosis
- Liver Diseases
- Lung Neoplasms
- Melanoma
- Multiple Myeloma
- Muscle Weakness
- Musculoskeletal Diseases
- Myalgia
- Neoplasms
- Neoplasms, Plasma Cell
- Neuroendocrine Tumors
- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Prolapse
- Raynaud Disease
- Scleroderma, Diffuse
- Scleroderma, Systemic
- Sinusitis
- Staphylococcal Infections
- Vascular Diseases
- Wounds and Injuries
- Wrist Injuries
Recent trials (50)
- NCT06613191Lead sponsorPhase 4Oct 1, 2024
- NCT05516641Overall official - principal investigatorN/AJul 25, 2022
- NCT05516641Lead sponsorN/AJul 25, 2022
- NCT05275686CollaboratorPhase 2Apr 20, 2022
- NCT05286593Lead sponsorPhase 4Dec 28, 2021
- NCT05286593Reponsible party - principal investigatorPhase 4Dec 28, 2021
- NCT04907526Overall official - principal investigatorPhase 1Jun 1, 2021
- NCT04907526CollaboratorPhase 1Jun 1, 2021
- NCT04669145Reponsible party - principal investigatorPhase 2/Phase 3Jan 1, 2021
- NCT04669145Lead sponsorPhase 2/Phase 3Jan 1, 2021
- NCT04155099Reponsible party - principal investigatorPhase 2Dec 31, 2019
- NCT04155099Lead sponsorPhase 2Dec 31, 2019
- NCT03901378Overall official - principal investigatorPhase 2Apr 30, 2019
- NCT03901378Reponsible party - principal investigatorPhase 2Apr 30, 2019
- NCT03901378Lead sponsorPhase 2Apr 30, 2019
Details
- Founded
- New Orleans, LA, US Jan 1, 1942
- Last known activity
- Oct 1, 2024